About Orbactiv
- Headquarter United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Melinta Therapeutics, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Menarini
(Oct 11, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Orbactiv
Detailed funding history for Orbactiv
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Orbactiv
Orbactiv has secured backing from 1 investor. Prominent investors backing the company include Menarini Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Menarini Group is engaged in pharmaceutical and healthcare solutions.
|
Locked | Locked | Locked |
Investor details for Orbactiv
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Orbactiv
Investment portfolio details for Orbactiv
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Orbactiv
Detailed financials for Orbactiv
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orbactiv Comparisons
Peer comparison for Orbactiv
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Orbactiv
Detailed competitors of Orbactiv
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orbactiv
Complete news archive for Orbactiv
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orbactiv
Orbactiv was founded in 2014.
Orbactiv is headquartered in United States.
Developer of a single-dose antibiotic for bacterial skin infections. This antibiotic offers an alternative treatment for acute bacterial skin and skin structure infections caused by specific gram-positive microorganisms. It provides a single-dose option compared to multiple-dose regimens, and the company offers support programs for insurance verification, billing, and patient assistance. The product has three mechanisms of action and is indicated for adult patients. Important safety information includes potential interactions with anticoagulants and the need for monitoring of certain coagulation tests. Adverse reactions are documented in the full prescribing information.
Orbactiv has 1 investor. Key investors include Menarini Group.